Literature DB >> 6653942

Increased platelet aggregability in diabetic children: relation to serum lipid and fatty acid composition.

U Ewald, M Kobbah, B Vessby, T Tuvemo.   

Abstract

Platelet aggregation was studied in 14 diabetic children with no signs of angiopathy and in 14 healthy matched control children. The magnitude of the platelet shape change after ADP stimulation was decreased in diabetic patients while the maximal aggregation after ADP and low dose collagen was significantly higher than in healthy control children. In 28 diabetic children the platelet shape change after ADP stimulation was positively correlated with the serum concentration of apolipoprotein A-I and negatively correlated with serum triglyceride concentration. The ratio between the fatty acids 20:3/20:4 in cholesterol esters was strongly correlated with the relative incidence of irreversible aggregation (p less than 0.001) and with the magnitude of the maximal aggregation (p less than 0.01) after ADP stimulation (3.3 mumol/l). The ratio between the polyunsaturated and saturated fatty acids in the triglyceride fraction was negatively correlated to the maximal aggregation after collagen stimulation (10 mg/l). This study shows tha platelet aggregation is increased early in the course of diabetes in childhood. It suggests that the abnormalities in platelet aggregation pattern in diabetic patients are related to several of the lipid factors associated with an increased risk of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653942     DOI: 10.1007/BF00282514

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Lipids, platelets, and atherosclerosis.

Authors: 
Journal:  Lancet       Date:  1980-03-01       Impact factor: 79.321

2.  Hypercholesterolemia and platelets.

Authors:  R S Lees; A C Carvalho
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

3.  Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode.

Authors:  U Ewald; T Tuvemo; G Rooth
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

4.  Changes of platelet phospholipids in diabetes mellitus.

Authors:  A Kalofoutis; J Lekakis
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

5.  Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography.

Authors:  K Silberbauer; G Schernthaner; H Sinzinger; H Freyler
Journal:  Atherosclerosis       Date:  1981 Aug-Sep       Impact factor: 5.162

6.  Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls.

Authors:  U Ewald; T Tuvemo; B Vessby; O Wålinder
Journal:  Acta Paediatr Scand       Date:  1982-01

7.  Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol.

Authors:  L A Carlson; L E Böttiger; P E Ahfeldt
Journal:  Acta Med Scand       Date:  1979

8.  Effect of a diet of polyunsaturated fats on some platelet-function tests.

Authors:  J R O'Brien; M D Etherington; S Jamieson
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

9.  Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.

Authors:  F E Preston; J D Ward; B H Marcola; N R Porter; W R Timperley; B C O'Malley
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

View more
  3 in total

1.  Platelet aggregability during the first two years of type 1 (insulin-dependent) diabetes mellitus in children.

Authors:  A M Kobbah; U Ewald; T Tuvemo
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

2.  Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Authors:  M M Landgraf-Leurs; T Ladik; B Smolka; T Bock; W Schramm; M Spannagl; R Landgraf
Journal:  Klin Wochenschr       Date:  1987-07-01

3.  Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications.

Authors:  K P Ratzmann; E Schimke; A Beitz; R Hildebrandt; C Taube
Journal:  Klin Wochenschr       Date:  1991-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.